Stock TLIS TALIS BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Delayed Nasdaq
Other stock markets
 10:00:07 2024-07-03 EDT 		5-day change 1st Jan Change
8.73 USD +2.71% Intraday chart for Talis Biomedical Corporation +2.71% +17.18%
05-08 Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-02 North American Morning Briefing : Stocks Seen -2- DJ

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North American Morning Briefing : Stocks Seen -2-
DJ
Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Talis Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Talis Biomedical Corporation Announces New Data Supporting the Development of Its Planned CT/NG/TV and Vinal Infections Panels
CI
Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Earnings Flash (TLIS) TALIS BIOMEDICAL CORPORATION Reports Q4 Revenue $0.3M
MT
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Earnings Flash (TLIS) TALIS BIOMEDICAL CORPORATION Posts Q3 Revenue $796,000
MT
Talis Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Earnings Flash (TLIS) TALIS BIOMEDICAL CORPORATION Posts Q2 Revenue $0.6M
MT
Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Talis Biomedical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
CI
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Talis Biomedical Corporation Announces Grant of FDA Emergency Use Authorization for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
CI
North American Morning Briefing : Blockbuster -3-
DJ
North American Morning Briefing : Stock Futures -3-
DJ
Talis Biomedical Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TLIS Stock
  4. News Talis Biomedical Corporation
  5. Highlights